New coronavirus antibody treatment by Eli-Lilly reduces need for hospitalization: study

A clinical trial assessing Eli Lilly’s experimental antibody treatment reduced the rate of hospitalization in COVID-19 patients, the pharmaceutical company's CEO David Ricks told FOX Business' Maria Bartiromo on Wednesday. “This is an important day in the fight against COVID,” Ricks said on “Mornings with Maria.”-- More...